• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Innovative Eyewear Inc. Reports Full Year 2024 Financial Results

    3/25/25 8:30:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care
    Get the next $LUCY alert in real time by email

    Revenue increased 42% over prior year

    MIAMI, March 25, 2025 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its full year 2024 financial results.

    An image of the upcoming Reebok Powered by Lucyd Voltage style. Courtesy Innovative Eyewear, Inc.

    Net revenue for the year ended December 31, 2024 was $1,636,440, an increase of 42% from revenue of $1,152,479 in the prior year. This increase was primarily attributable to growth in unit sales volume, largely driven by product launches during 2024 of the co-branded Nautica® Powered by Lucyd and Eddie Bauer® Powered by Lucyd collections, as well as the Lucyd Armor safety smart glasses line. Also contributing to the growth in revenues were the Company's continued investments in marketing and advertising initiatives, as well as increased public interest and growth in smart glasses and the wearable products category.

    Gross profit margin for 2024 was 13%, compared with negative 10% for 2023. This improvement in gross profit margin was mainly attributable to improvements related to the cost of frames (which added 13 percentage points to gross profit margin) and in the cost of lenses (which added 8 percentage points to gross profit margin) compared to 2023.

    Total operating expenses in 2024 were $8,138,892, a 21% percent increase from total operating expenses of $6,736,213 in 2023. This increase was primarily the result of an increase in 2024 of $659,144, or 32%, in sales and marketing expense in order to drive sales growth, and an increase of $586,332, or 15%, in general and administrative expense, including an increase in legal costs of $318,000 largely as a result of various shareholder and equity-related matters during the current year period, compared to 2023.

    The Company had a net loss in 2024 of $7,766, 515, or $(5.19) per share, compared with a net loss of $6,663,428, or $(10.87) per share, in 2023.

    Weighted average number of shares outstanding was 1,496,357 at December 31, 2024, and 613,000 at December 31, 2023.

    Cash and cash equivalents at December 31, 2024 were $2,628,987, in addition the Company held $4,895,184 in short-term U.S. Treasury investments as of December 31, 2024, vs cash and cash equivalents of $4,287,447 held in the prior year.  Management believes that including such investments as part of the Company's overall liquidity, would provide a more accurate depiction of the Company's liquidity and economic position.

    Non-current liabilities at December 31, 2024 were $5,450, and $35,450 at December 31, 2023.

    Net cash flows from financing activities were $10,243,327 in 2024 and $6,661,394 in 2023.

    For the fourth quarter ended December 31, 2024, net revenue was $690,688, the Company's highest quarterly revenue since inception and an increase of 12% compared with the fourth quarter in 2023.  

    Gross profit margin for the fourth quarter ended December 31, 2024 improved by 43 percentage points to 14%, compared to negative 29% for the same quarter in 2023. This improvement was primarily due to supplier changes resulting in higher quality products and lower manufacturing costs, as well as improved economies of scale driven by higher unit sales volumes.

    During the fourth quarter of 2024, Innovative Eyewear also announced several milestones, including:

    • the launch of Lucyd Armor™, the first ANSI-certified smart safety glasses for all-day wear
    • CSA certification on the Armor, making it available for safety use in Canada as well as the USA.
    • the launch of four new smart glasses with enhanced features and improvements to the core Lucyd Lyte product line, including the use of advanced TR90 plastic for improved adjustability and durability
    • a successful Vision Expo West trade show, resulting in new optical stores onboarding the company's smart frames and bringing the total number of such stores to over 400.
    • a new retail partnership with Nebraska Furniture Mart, bringing the full range of the Company's smart eyewear products to this Berkshire Hathaway-owned leading Midwestern retailer
    • the launch of the first-ever generative AI fashion show for eyewear

    An image of the upcoming Reebok Powered by Lucyd Voltage style. Courtesy Innovative Eyewear, Inc.

    Future Outlook

    Following its launches of three new lines of smart glasses in 2024 (Nautica® Powered by Lucyd, Eddie Bauer® Powered by Lucyd , and Lucyd Armor), the Company anticipates launching the Reebok® Powered by Lucyd sport smart glasses line in the second quarter of 2025, and a Reebok® Optical Smart Eyewear collection latter in 2025.

    The Company also continues to actively pursue distribution of its products through major national retailers, which management believes, if successful, could have a positive material impact on revenues in the next three to 12 months.

    Harrison Gross, CEO of Innovative Eyewear Inc., commented,

    "Our 2024 fourth quarter revenue was our best quarter yet, and we have continued the trend of outperforming sales each quarter on a year-over-year basis, for the last 18 months. As we look ahead to 2025, we believe we are well positioned to build on our momentum and significantly grow both our total revenues and our market share. I am particularly excited about the potential of our upcoming Reebok® product lines which we will be launching in 2025 coupled with the continued significant traction of the Lucyd ArmorTM smart safety glasses."

    About Innovative Eyewear, Inc.

    Innovative Eyewear is a developer of cutting-edge ChatGPT enabled smart eyewear, under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands. True to our mission to Upgrade Your Eyewear®, our Bluetooth audio glasses allow users to stay safely and ergonomically connected to their digital lives and are offered in hundreds of frame and lens combinations to meet the needs of the optical market. To learn more and explore our continuously evolving collection of smart eyewear, please visit www.lucyd.co.

    Forward-Looking Statements

    This press release contains certain forward-looking statements, including those relating to the Company's business operations, projections, market position, introduction of future product lines and developments. Forward-looking statements are based on the Company's current expectations and assumptions. The Private Securities Litigation Reform Act of 1995 provides a safe-harbor for forward-looking statements. These statements may be identified by the use of forward-looking expressions, including, but not limited to, "anticipate," "believe," "continue," "estimate," "expect," "future," "intend," "may," "outlook," "plan," "potential," "predict," "project," "should," "will," "would" and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K under the caption "Risk Factors."

    Investor Relations Contact: 

    Scott Powell

    Skyline Corporate Communications Group, LLC

    Telephone: +1 (646) 893-5835

    Email: [email protected]

     

    INNOVATIVE EYEWEAR, INC.

    BALANCE SHEETS

    December 31, 2024 and 2023

























    2024



    2023

    ASSETS









      Current Assets









          Cash and cash equivalents



    $          2,628,987



    $          4,287,447

          Investments in debt securities (U.S. Treasury bills)



    4,895,184



    -

          Accounts receivable, net



    107,918



    93,211

          Prepaid expenses



    266,935



    313,648

          Inventory prepayments



    424,594



    323,520

          Inventory



    831,757



    533,239

          Due from Tekcapital and Affiliates



    23,394



    6,256

          Other current assets



    59,447



    59,447

              Total Current Assets



    9,238,216



    5,616,768











       Non-Current Assets









          Patent costs, net



    451,302



    286,429

          Capitalized software costs



    -



    88,073

          Property and equipment, net



    107,562



    154,848

          Other non-current assets



    41,229



    72,644

    TOTAL ASSETS



    $          9,838,309



    $          6,218,762











    LIABILITIES AND STOCKHOLDERS' EQUITY









      Liabilities









         Current Liabilities









            Accounts payable and accrued expenses



    $             692,817



    $             581,986

            Deferred revenue



    44,901



    42,500

                    Total Current Liabilities



    737,718



    624,486











         Non-Current Liabilities









            Deferred revenue



    5,450



    35,450

    TOTAL LIABILITIES



    743,168



    659,936











    Commitments and contingencies (see Note 7)



    -



    -











    Stockholders' Equity 









    Common stock (par value $0.00001, 50,000,000 shares authorized, and 2,452,632 and 747,416 shares

    issued and outstanding as of December 31, 2024 and 2023, respectively) (1)



    25



    7

    Additional paid-in capital (1)



    33,831,046



    22,528,234

    Accumulated deficit



    (24,735,930)



    (16,969,415)

                    TOTAL STOCKHOLDERS' EQUITY



    9,095,141



    5,558,826

    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 



    $          9,838,309



    $          6,218,762





















    (1)

    The values of Common stock and Additional paid-in capital, as well as the number of shares issued and outstanding, have been retroactively adjusted in order to give effect to the Company's 1-for-20 reverse stock split. See Note 2 and Note 8.

     

    INNOVATIVE EYEWEAR, INC.

    STATEMENTS OF OPERATIONS

     CONDENSED STATEMENTS OF OPERATIONS

    For the years ended December 31, 2024 and 2023





















    Year ended





    Year ended











    December 31,





    December 31,











    2024





    2023





    Change 





















    Revenues, net

    $     1,636,440

    100 %



    $     1,152,479

    100 %



    $       483,961

    42 %

    Less: Cost of Goods Sold

    (1,421,250)

    87 %



    (1,271,808)

    110 %



    (149,442)

    12 %

          Gross Profit (Deficit)

    215,190

    13 %



    (119,329)

    -10 %



    334,519

    280 %



















    Operating Expenses:

















        General and administrative

    (4,473,292)

    273 %



    (3,886,960)

    337 %



    (586,332)

    15 %

        Sales and marketing

    (2,706,213)

    165 %



    (2,047,069)

    178 %



    (659,144)

    32 %

        Research and development

    (819,387)

    50 %



    (662,184)

    57 %



    (157,203)

    24 %

        Related party management fee

    (140,000)

    9 %



    (140,000)

    12 %



    -

    0 %

           Total Operating Expenses

    (8,138,892)

    497 %



    (6,736,213)

    584 %



    (1,402,679)

    21 %



















        Other Income (Expense)

    157,187

    10 %



    195,150

    17 %



    (37,963)

    -19 %

        Interest Expense

    -

    0 %



    (3,036)

    0 %



    3,036

    100 %

            Total Other Income (Expense), net

    157,187

    10 %



    192,114

    17 %



    (34,927)

    -18 %





































    Net Loss 

    $   (7,766,515)

    475 %



    $   (6,663,428)

    578 %



    $   (1,103,087)

    17 %



















     

    Innovative Eyewear Logo (PRNewsfoto/Innovative Eyewear, Inc.)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/innovative-eyewear-inc-reports-full-year-2024-financial-results-302409943.html

    SOURCE Innovative Eyewear, Inc.

    Get the next $LUCY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LUCY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LUCY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Innovative Eyewear Inc. Reports Q1 2025 Unaudited Financial Results

      Revenue and gross margins improvements MIAMI, May 13, 2025 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its Q1 2025 Unaudited financial results. Net revenue for the quarter ended March 31, 2025 was $454,501 an increase of 19% from revenue of $383,471 in the quarter ended March 31, 2024. This increase was primarily attributable to growth in unit sales volume, largely driven by product launches during 2024 of the co-branded Nautica® Powered by Lucyd and

      5/13/25 5:49:00 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Innovative Eyewear Partners with Eye Recommend, Expanding Smart Eyewear Access Across 600+ Independent Optometry Stores

      MIAMI, May 5, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. (NASDAQ:LUCY, LUCYW)), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announces that it has partnered with Eye Recommend to provide its smart eyewear to more than 600 independent optical practices across Canada, significantly broadening accessibility of Innovative Eyewear's smart eyewear throughout the Canadian market. Buying groups like Eye Recommend serve an important function in the optical industry landscape, making it easier for independent optometrists to access

      5/5/25 8:00:00 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Innovative Eyewear Launches Reebok® Smart Eyewear

      MIAMI, April 28, 2025 /PRNewswire/ -- Innovative Eyewear Inc. (NASDAQ:LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced the launch of Reebok Smart Eyewear, available worldwide on Lucyd.co. Expanded availability is expected later this quarter on Reebok.com and select online and traditional retailers. A Landmark Product Launch The global smart glasses market is projected to reach approximately $13 billion worldwide by 20301. We believe Reebok Powered by Lucyd smart eyewear positions Innovative Eyewear at the forefr

      4/28/25 8:00:00 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    Leadership Updates

    Live Leadership Updates

    See more
    • Innovative Eyewear, Inc. Signs Professional Football Player Emmanuel Ogbah as Brand Ambassador

      MIAMI, Dec. 14, 2023 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW))), the developer of the developer of ChatGPT smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, is pleased to announce the signing of Emmanuel Ogbah as an official brand ambassador. Emmanuel Ikechukwu Ogbah is a Nigerian professional football defensive end for the Miami Dolphins. He played college football at Oklahoma State and was drafted by the Cleveland Browns in the second round of the 2016 NFL Draft. Lucyd eyewear's open-ear au

      12/14/23 8:30:00 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    SEC Filings

    See more
    • SEC Form 10-Q filed by Innovative Eyewear Inc.

      10-Q - Innovative Eyewear Inc (0001808377) (Filer)

      5/13/25 4:30:26 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • SEC Form S-1 filed by Innovative Eyewear Inc.

      S-1 - Innovative Eyewear Inc (0001808377) (Filer)

      5/9/25 4:05:44 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • SEC Form SCHEDULE 13G filed by Innovative Eyewear Inc.

      SCHEDULE 13G - Innovative Eyewear Inc (0001808377) (Subject)

      4/17/25 4:04:00 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Large owner Galkin Vladimir bought $721,472 worth of shares (70,000 units at $10.31) and sold $148,896 worth of shares (14,037 units at $10.61) (SEC Form 4)

      4/A - Innovative Eyewear Inc (0001808377) (Issuer)

      9/27/24 4:12:34 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: Large owner Galkin Vladimir bought $1,822,973 worth of shares (200,792 units at $9.08) (SEC Form 4)

      4/A - Innovative Eyewear Inc (0001808377) (Issuer)

      9/27/24 2:41:40 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: Large owner Galkin Vladimir bought $2,649,148 worth of shares (297,443 units at $8.91) and sold $384,100 worth of shares (42,328 units at $9.07) (SEC Form 4)

      4/A - Innovative Eyewear Inc (0001808377) (Issuer)

      9/27/24 2:40:55 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    Financials

    Live finance-specific insights

    See more
    • Innovative Eyewear Inc. Reports Third Quarter 2024 Financial Results

      Revenue Increased 14% in Q3 2024 vs Q3 2023, and 76% on a Year-to-Date Basis vs 2023 MIAMI, Nov. 13, 2024 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), a developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its financial results for the third quarter of 2024. Net revenue for the quarter ended September 30, 2024 was $253,599, an increase of 14% from the quarter ended September 30, 2023. This year-over-year increase was primarily attributable to strategic reductions in price discounts and other adjustments to o

      11/13/24 8:00:00 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Innovative Eyewear, Inc. Adopts Limited Duration Stockholders Rights Plan

      MIAMI, Sept. 25, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced that its Board of Directors has approved the adoption of a limited duration stockholder rights plan (the "Rights Plan") and declared a dividend distribution of one right ("Right") for each outstanding share of common stock. The record date for such dividend distribution is September 25, 2024. The Rights Plan expires, without any further action being required to be taken by Innovative Eyewear's Board of Directors, on September 25, 2025 or at such earlier time as disclos

      9/25/24 8:20:00 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Innovative Eyewear Inc. Reports Second Quarter 2024 Financial Results

      Quarterly Revenue Increased 82% vs Q2 2023; Gross Margin Increases Substantially MIAMI, Aug. 13, 2024 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW))), the developer of ChatGPT-enabled smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its financial results for the second quarter of 2024. Net revenue for the quarter ended June 30, 2024 was $308,682, an increase of 82% from the quarter ended June 30, 2023. Net revenue for the six months ended June 30, 2024 was $692,153, an increase of 120% vs. the comparable period in 2023.

      8/13/24 8:00:00 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Gayle Oswald

      3 - Innovative Eyewear Inc (0001808377) (Issuer)

      10/25/24 9:59:55 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: Large owner Galkin Vladimir bought $721,472 worth of shares (70,000 units at $10.31) and sold $148,896 worth of shares (14,037 units at $10.61) (SEC Form 4)

      4/A - Innovative Eyewear Inc (0001808377) (Issuer)

      9/27/24 4:12:34 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: Large owner Galkin Vladimir bought $1,822,973 worth of shares (200,792 units at $9.08) (SEC Form 4)

      4/A - Innovative Eyewear Inc (0001808377) (Issuer)

      9/27/24 2:41:40 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Innovative Eyewear Inc.

      SC 13G/A - Innovative Eyewear Inc (0001808377) (Subject)

      11/13/24 11:18:48 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Innovative Eyewear Inc.

      SC 13D/A - Innovative Eyewear Inc (0001808377) (Subject)

      10/4/24 4:43:00 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Innovative Eyewear Inc.

      SC 13D/A - Innovative Eyewear Inc (0001808377) (Subject)

      9/25/24 4:17:38 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care